http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-200800295-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-325
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-27
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-27
filingDate 2006-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2008-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-200800295-A1
titleOfInvention METHODS OF TREATMENT OF EPILEPTOGENESIS
abstract The invention is directed to a method for preventing, treating, reversing, inhibiting or stopping epileptogenesis in a subject comprising administering to the subject in need of a therapeutically effective amount of a compound selected from the group consisting of formula (I) and formula (II), or its pharmaceutically acceptable salt or ester in which phenyl is substituted on X with halogen atoms, from one to five, selected from the group consisting of fluorine, chlorine, bromine and iodine, a R, R, R, R, R and R are independently selected from the group , comp hydrogen and C-C alkyl groups in which C-C-alkyl is optionally substituted phenyl (in which phenyl is optionally substituted with substituents independently selected from the group consisting of halogen, C-C-alkyl, C -C-alkoxy groups, amino groups, nitro groups and cyano groups).
priorityDate 2005-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556587
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554831
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID807
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655

Total number of triples: 29.